Clinical Trials · NCT03693430
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 304
- Start date
- Oct 2018
- Locations
- 41 sites, 5 countries
- Primary endpoint
- Percentage Change From Baseline (Week 0) to Week 104 in Body Weight